化工社化工社 化学情報印刷レポート · 研究参考用
Piperazine Dihydrochloride → Irbesartan
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | Piperazine Dihydrochloride | HCID 8893 | — |
| 反応物 | Sodium Azide | HCID 33557 | — |
| 反応物 | 4'-((2-Butyl-4-oxo-1,3-diazaspiro(4.4)non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile | HCID 9843116 | — |
| 溶媒 | O-Xylene | HCID 7237 | — |
| 生成物 | Irbesartan | HCID 3749 | 96% |
反応手順
A mixture of 2-n-butyl-3-[(2′-cyanobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one (10 g), sodium azide (7.7 g) and piperazine dihydrochloride (7.5 g) in xylene (30 ml) was refluxed for 7 hours under stirring. The reaction was cooled to room temperature and extracted with 5% NaOH solution. The pooled alkaline solution was washed with toluene or xylene (15 ml) and the aqueous phase neutralized to pH 6.5 using concentrated HCL. The resulting suspension was stirred for 3 hours at room temperature and filtered obtain irbesartan (3.6 g, 96% purity by HPLC).
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US08080670B2 |
| 出典データセット | uspto-grants-2011_12 |
| ORD ID | ord-a67296b3abe540c4a17ddd7e7fd19fb6 |
| 出典メモ | uspto-grants-2011_12 |